- Price
- 46.00p
- Market cap
- £79m
- 1M
- -4.3%
- 3M
- +0.0%
- 1Y
- +0.1%
- P/E (trailing)
- —
- Dividend yield
- —
“As a result of continued strong performance in Q3 FY26 and confidence in trading plans for Q4, the Board now expects FY26 Adjusted EBITDA1 to be materially ahead of market expectations.”
adjusted EBITDA
“The Board remains focused on delivering strong double-digit growth and is confident in the Company delivering FY26 full-year results in line with market expectations3.”
adjusted EBITDA · stated consensus £3.7m
“Looking ahead, we remain focused on delivering sustained double-digit growth. The Board currently expects FY26 results to be in line with market expectations*. *Note: Immediately before publication of this announcement, the Board believes that market expectations for the year ending 31 December 2026 to be ... Adjusted EBITDA (excluding fair value adjustment to biological produce) of £3.7m...”
adjusted EBITDA · stated consensus £3.7m
“Furthermore, the Board now expects Adjusted EBITDA to be in the range of £4.0m - £4.5m, ahead of market expectations. This is primarily driven by an improvement in underlying profitability, whilst the Fair Value adjustment to Biological Produce is also expected to be slightly higher than market expectations, supported by a high quality and above-average harvest yield.”
Last 24 months of trading updates, one verdict per announcement (the headline profit measure first). Companies report these themselves and lean positive, so compare against peers: the same tag-based peer group as the Overview, counting peers with at least 2 updates and needing at least 3. Verdicts are machine-extracted; where the quoted wording clearly says otherwise, the wording is used.
“As a result of continued strong performance in Q3 FY26 and confidence in trading plans for Q4, the Board now expects FY26 Adjusted EBITDA1 to be materially ahead of market expectations.”
adjusted EBITDA
“The Board remains focused on delivering strong double-digit growth and is confident in the Company delivering FY26 full-year results in line with market expectations3.”
adjusted EBITDA · stated consensus £3.7m
“Looking ahead, we remain focused on delivering sustained double-digit growth. The Board currently expects FY26 results to be in line with market expectations*. *Note: Immediately before publication of this announcement, the Board believes that market expectations for the year ending 31 December 2026 to be ... Adjusted EBITDA (excluding fair value adjustment to biological produce) of £3.7m...”
adjusted EBITDA · stated consensus £3.7m
“Furthermore, the Board now expects Adjusted EBITDA to be in the range of £4.0m - £4.5m, ahead of market expectations. This is primarily driven by an improvement in underlying profitability, whilst the Fair Value adjustment to Biological Produce is also expected to be slightly higher than market expectations, supported by a high quality and above-average harvest yield.”
Last 24 months of trading updates, one verdict per announcement (the headline profit measure first). Companies report these themselves and lean positive, so compare against peers: the same tag-based peer group as the Overview, counting peers with at least 2 updates and needing at least 3. Verdicts are machine-extracted; where the quoted wording clearly says otherwise, the wording is used.
adjusted EBITDA
adjusted EBITDA